• 中国核心期刊(遴选)数据库收录期刊
  • 中文科技期刊数据库收录期刊
  • 中国期刊全文数据库收录期刊
  • 中国学术期刊综合评价数据库统计源期刊等

• 药品评价-临床研究 • 上一篇    下一篇

逍遥散加减治疗原发性失眠的疗效观察

汪洋   

  1. 沈阳市和平区沈水湾社区卫生服务中心中医科
  • 收稿日期:2015-11-23 修回日期:2015-11-23 出版日期:2015-12-25 发布日期:2015-12-25

Observation on the Efficacy for Treatment of Primary Insomnia by Xiaoyao Powder

  1. Shenshui bend community health service center , Heping District,Shenyang
  • Received:2015-11-23 Revised:2015-11-23 Online:2015-12-25 Published:2015-12-25

摘要: 目的: 观察逍遥散加减治疗原发性失眠的临床疗效。方法:采用临床随机对照试验方法,筛选符合纳入标准的失眠患者90例,其中试验组46例采用逍遥散加减治疗,对照组44例给予口服艾司唑仑治疗,4周1疗程, 4周后随访。以匹兹堡睡眠质量指数(PSQI)为观察指标,采集并统计基线期、治疗后、随访期3个时点疗效相关数据,比较两种疗法的疗效差异。结果:治疗后试验组总有效率84.78%,对照组总有效率79.54 %,两组总有效率无显著差异(χ2=0.422,P=0.588>0.05);随访期试验组总有效率82.60%,对照组总有效率61. 36 %,两组总有效率有显著差异(χ2=5.060,P=0.034<0.05)。结论:逍遥散与艾司唑仑对原发性失眠均有较好的即时疗效,但逍遥散的远期疗效更优,更宜临床推广。

Abstract: Objective: To observe the clinical effects of xiaoyao powder treatment for primary insomnia. Methods: The totally 90 patients with the primary insomnia are divided into 2 groups in a single-blind way randomly. The treatment group(46) chose the xiaoyao powder while the control group(44) chose the estazolan tablets. A course including 4 weeks and one month after the treatment there was a follow-up treatment. By taking Pittsburgh sleep quality index (PSQI) as the observation target, collecting and summarizing the data of baseline period, after treatment period and follow-up period, we could get a statistical results of efficacy of the 2 kinds of treatments for the immediate and long-term clinical curative effects of primary insomnia. Results:The total effective rate of the after treatment period in treatment group was 84.78%, while the control group was 79.54%, which show that there was no significant difference between the two groups (χ2=0.422,P=0.588>0.05). But the data of the follow-up period in treatment group was 82.60%, while the control group was 61.36%, which show that there′s a significant difference between the 2 groups (χ2=5.060,P=0.034<0.05). Conclusion: Xiaoyao powder and estazolan tablets are both have good instant curative effect in primary insomnia. But xiaoyao powder is superior to estazolan tablets on long-term curative effect and lasting effect, so it′s more suitable for clinical promotion.